Orthofix International (OFIX) Cash Flow Statement

Click line-items for a historical chart and %

Net income (loss)
Depreciation and amortization
Amortization of debt costs
Provision for doubtful accounts
Deferred income taxes
Share-based compensation
Provision for inventory obsolescence
Gain on interest rate swap
Gain on sale of vascular operations (Note 16)
Tax benefit on non-qualified stock options
Other
Trade accounts receivable
Inventories
Prepaid expenses and other current assets
Trade accounts payable
Charges related to U.S. Government inquiries
Other current liabilities
Net cash provided by operating activities	38.4M
Capital expenditures for property, plant and equipment	-12.93M
Capital expenditures for intangible assets	-1.33M
Payment made in connection with acquisition
Net proceeds from sale of vascular operations	0
Net cash (used in) provided by investing activities	-17.87M
Net proceeds from issuance of common shares	19.69M
Repayments of long-term debt
Payment of refinancing fees
Proceeds from (repayment of) bank borrowings, net
Change in restricted cash	0
Cash payment for purchase of minority interest in subsidiary
Tax benefit on non-qualified stock options
Net cash provided by (used in) financing activities	-37.66M
Effect of exchange rate changes on cash	301K
Net increase in cash and cash equivalents	-16.84M
Cash and cash equivalents at the beginning of the period	63.66M
Cash and cash equivalents at the end of the period	46.82M

Entities mentioned with OFIX

View All Entities